REV-MED recently participated in the Korean Society for Stem Cell Research (KSSCR) conference, held from August 14–15, where it presented clinical cases for its NovaStem brand, focusing on blood and adipose-derived stem cells.
Launch of NovaStem
In August, REV-MED launched NovaStem, advancing its TriCell Kit, which extracts and concentrates growth and regenerative factors from blood, bone marrow, and adipose tissue. This new product line includes:
- NovaStem Blood Cell (BC): A system for enhanced blood stem cell extraction.
- NovaStem Bone Marrow Aspirate Concentrate (BMAC): An advanced solution for bone marrow-derived therapies.
Conference Highlights
Dr. Hyun-Seung Kim of Modeline Clinic presented clinical applications of NovaStem Blood Cell under the topic, Intravenous and Local Injections Using NovaStem Kits for Disease Treatment and Aging Prevention.
Dr. Leong Chung Lan from Celgen Clinic in Kuala Lumpur, Malaysia, discussed the DUOCell SVF system for adipose-derived stem cells, focusing on its use in aesthetics and regenerative medicine.
Commitment to Stem Cell Innovation
Edward BG Shin, CEO of REV-MED, remarked, “The domestic market for autologous stem cell therapy and aesthetics is rapidly expanding. We are dedicated to developing Korea’s leading autologous stem cell therapy systems and becoming a globally recognized company in this field.”
About REV-MED
Founded in 2009, REV-MED specializes in extracting autologous stem cells from blood, bone marrow, and adipose tissue. The company develops systems to selectively isolate regenerative factors for transplantation and supplies its advanced stem cell therapy solutions to hospitals worldwide.
Source: HealthTrends (http://www.k-health.com)
REV-MED recently participated in the Korean Society for Stem Cell Research (KSSCR) conference, held from August 14–15, where it presented clinical cases for its NovaStem brand, focusing on blood and adipose-derived stem cells.
Launch of NovaStem
In August, REV-MED launched NovaStem, advancing its TriCell Kit, which extracts and concentrates growth and regenerative factors from blood, bone marrow, and adipose tissue. This new product line includes:
Conference Highlights
Dr. Hyun-Seung Kim of Modeline Clinic presented clinical applications of NovaStem Blood Cell under the topic, Intravenous and Local Injections Using NovaStem Kits for Disease Treatment and Aging Prevention.
Dr. Leong Chung Lan from Celgen Clinic in Kuala Lumpur, Malaysia, discussed the DUOCell SVF system for adipose-derived stem cells, focusing on its use in aesthetics and regenerative medicine.
Commitment to Stem Cell Innovation
Edward BG Shin, CEO of REV-MED, remarked, “The domestic market for autologous stem cell therapy and aesthetics is rapidly expanding. We are dedicated to developing Korea’s leading autologous stem cell therapy systems and becoming a globally recognized company in this field.”
About REV-MED
Founded in 2009, REV-MED specializes in extracting autologous stem cells from blood, bone marrow, and adipose tissue. The company develops systems to selectively isolate regenerative factors for transplantation and supplies its advanced stem cell therapy solutions to hospitals worldwide.
Source: HealthTrends (http://www.k-health.com)